| (GBp) | Dec 2021 | Y/Y change |
|---|---|---|
| Revenue | 118.35K | -6.57% |
| Operating expense | — | — |
| Net income | -8.17M | 19.15% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMM.L returned +119.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -45.1% |
| 1 year | +119.0% |
| 5 years | -56.4% |
| 10 years | -90.7% |
| All-time high | GBX 170.00 (Dec 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in IMM.L would be worth today ›No. ImmuPharma plc has not paid a dividend in the past 12 months.
ImmuPharma plc is part of the Healthcare sector.
ImmuPharma plc has a market cap of 21.24M GBp, based on the latest quote.
